HD-OPM Archive
Topics › Supplements & vitamins

Hesperidin plus exercise: 64% vs 33% left metabolic syndrome; related trial retracted

Louis Nervegna · Mar 02, 2026 · ♥ 16 reactions · 2 comments · original Facebook post
Supplements & vitaminsInsulin resistance & diabetes
AI summary & key facts

Summary of a small 12-week trial of 1,000 mg/day hesperidin with diet and exercise in metabolic syndrome, reporting better glucose, triglycerides, blood pressure and inflammatory markers. The link metadata shows an earlier hesperidin metabolic syndrome RCT in Eur J Nutr was retracted, so the evidence should be treated cautiously.

A small 12-week clinical trial in patients with metabolic syndrome found that adding 1,000 mg/day of the flavonoid hesperidin to diet and exercise nearly doubled the number of participants who moved out of the metabolic syndrome range: 64% of those taking hesperidin no longer met diagnostic criteria, compared to 33% in the placebo group. Improvements were seen in fasting glucose, insulin sensitivity, triglycerides, blood pressure, and inflammatory markers.

Renue By ScienceHesperidin + Exercise Improves Metabolic Syndrome Markers12-week RCT: 1,000mg/day hesperidin helped 64% of metabolic syndrome patients exit diagnosis vs. 33% placebo. Improved fasting glucose, triglycerides, TNF-α, and blood pressure.renuebyscience.com

The results suggest hesperidin may enhance the metabolic benefits of lifestyle intervention in people at elevated cardiometabolic risk.

Link to full study:

Paper · Eur J Nutr · 2020RETRACTED ARTICLE: The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical triallink.springer.com

Quoted:

“In this clinical trial with a parallel-group design, 49 patients with MetS [metabolic syndrome] received either 500-mg hesperidin or placebo, twice daily, for 12 weeks.”

“Compared with the placebo group, hesperidin decreased fasting glucose level (− 6.07 vs. − 13.32 mg/dL, P = 0.043), triglyceride (− 8.83 vs. − 49.09 mg/dL, P = 0.049), systolic blood pressure (− 0.58 vs. − 2.68 mmHg, P = 0.048) and TNF-α (− 1.29 vs. − 4.44 pg/mL, P = 0.009). Based on the within-group analysis, hesperidin led to significant decrease in serum levels of glucose, insulin, triglyceride, total cholesterol, low density lipoprotein cholesterol, TNF-α and hs-CRP, while in control group only glucose and insulin significantly decreased.”

“The results indicate that hesperidin supplementation can improve metabolic abnormalities and inflammatory status in patients with MetS.”

My note:

The following review article was recently published. It outlines the evidence for hesperidin as a treatment for metabolic syndrome. One of hesperidin’s main mechanisms of action in treating metabolic syndrome is its ability to activate PPAR-gamma, the same pathway used by the thiazolidinedione class of diabetes drugs (e.g. pioglitazone):

Paper · Natural Product Communications · 2026Hesperidin as an Emerging Nutraceutical for Management of Diverse Metabolic Syndrome: A Narrative Review on in vivo and in silico ExperimentsHesperidin, a flavonoid predominantly found in citrus fruits, has gained attention as a potential nutraceutical for managing various components of metabolic syndrome, including obesity, hypertension, dyslipidemia, and insulin resistance. This review aims to provide a comprehensive overview of the pharmacological properties of hesperidin, emphasizing its therapeutic potential in combating metabolic syndrome through…journals.sagepub.com

#hesperidinHD #metabolicsyndromeHD #insulinresistanceHD #glucoseHD #inflammationHD #ppargammaHD

Research cited

← newer: Nicotinamide (vitamin B3) prevented skin cancer in high-riskolder: DISCO-CT: DASH diet plus statins reversed soft plaque by 39. →